Immune to Cancer: The CRI Blog
-
ASCO 2016 Update: Immunotherapy Strategies for Women’s Cancers
Improving immunotherapy for breast, ovarian, and gynecological cancer patients.
-
ASCO 2016 Update: Checkpoint Immunotherapy Advances in Solid Cancers
New insights, approaches to improve outcomes in melanoma, kidney, bladder, and colorectal cancers.
-
ASCO 2016 Update: Biomarker-Based Strategies
Molecular clues may help predict patient treatment and outcomes.
-
ASCO 2016 Update: Advances in Immunotherapy for Lung and Blood Cancers
Combination checkpoints, improved CAR T cells show promise.
-
ASCO 2016 Update: The Value of Combination Immunotherapy
Activating multiple immune pathways to improve patient outcomes.
-
ASCO 2016 Update: The Personal Side of Immunotherapy
To help more patients, treatments must get personal.
-
Inmunoterapia vs. Quimioterapia: ¿Cual es la diferencia?
Respondemos las preguntas frecuentes de los pacientes sobre las diferencias entre la inmunoterapia y la quimioterapia, incluidos…
-
ASCO 2016: The Year of Immunotherapy
Chicago hosts top clinical cancer conference, immunotherapy shines.
-
The Evolution of Cancer Treatment: From Simplistic Strategies to Personalized Prescriptions
Immunotherapy, personalized medicine poised to revolutionize cancer treatment.
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.